Acute Angle Closure from Excessive Rizatriptan Use in the Setting of a Topiramate Restart: A Case Report
Journal of Acute Care Pharmacotherapy · 01.12.2025 · 1 (1)
DOI: 10.67122/001c.144882 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Acute Care Pharmacotherapy, online erschienen am 01.12.2025. Verfasst von Christian Kroll und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To report the successful identification and treatment of a 47-year-old male that experienced acute angle closure likely from the combination of multiple days of repeated doses of rizatriptan and the reinitiation of topiramate for migraine prophylaxis. Case Summary In this case report, we present a case of medication-induced acute angle closure involving topiramate and rizatriptan. A 47-year-old male with a history of migraines was prescribed topiramate and rizatriptan. He initially took topiramate for a year for presumed occipital neuralgia with minimal relief. The patient then stopped the topiramate due to a presumed lack of efficacy. After a year off of the topiramate, he reinitated therapy along with rizatriptan following discussion with his primary care provider. He used rizatriptan intermettiently for one week and stopped after improvement in his headache symptoms. He felt his headache return after a week of self-discontinuation, so he restarted his rizatriptan but now was administering two doses daily for the next six consecutive days. He then experienced blurred vision, brow ache, and emesis on the seventh day following his higher dose of rizatriptan reinitiation. Evaluation in the emergency department revealed elevated intraocular pressure and bilateral angle closure. Treatment with acetazolamide, methylprednisolone, ocular drops, and the cessation of rizatriptan and topiramate resolved his symptoms.
Conclusion
The extended and high utilization of rizatriptan and simultaneous use of topiramate most likely precipitated acute angle closure in this patient case. Prescribers and pharmacists should consider this potential complication in the differential diagnosis for patients presenting with similar symptoms as there is growing evidence suggesting an interaction between topiramate and triptan agents.
Zitieren
APA
Kroll, C., Tadros, S., Nguyen, L., & Wilkinson, B. (2025). Acute Angle Closure from Excessive Rizatriptan Use in the Setting of a Topiramate Restart: A Case Report. Journal of Acute Care Pharmacotherapy, 1(1). https://doi.org/10.67122/001c.144882
Vancouver
Kroll C, Tadros S, Nguyen L, Wilkinson B. Acute Angle Closure from Excessive Rizatriptan Use in the Setting of a Topiramate Restart: A Case Report. Journal of Acute Care Pharmacotherapy. 2025;1(1). doi:10.67122/001c.144882
BibTeX
@article{Kroll2025,
author = {Kroll, Christian and Tadros, Samuel and Nguyen, Laura and Wilkinson, Benjamin},
title = {Acute Angle Closure from Excessive Rizatriptan Use in the Setting of a Topiramate Restart: A Case Report},
journal = {Journal of Acute Care Pharmacotherapy},
year = {2025},
volume = {1},
number = {1},
doi = {10.67122/001c.144882}
}
EUVIMED